Immuneering Corporation - Class A — Quarterly Financial Statistics (NASDAQ:IMRX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities -13.47 M-14.51 M-14.08 M-9.45 M-11.98 M -50.01 M Cash from investing activities -5.42 M5.49 M-8 945-2 116-7 255 5.47 M Cash from financing activities 4.36 M-40.99 K13.81 M-61.96 K213.19 M 226.9 M Free cash flow -13.48 M-14.52 M-14.09 M-9.45 M-11.98 M -50.04 M

新闻

Immuneering’s (IMRX) chief business officer buys $24,990 in stock

Diretor da Immuneering, Schall, compra ações no valor de US$ 101 mil

Diretora de pessoas da Immuneering, Neufeld, compra US$ 10.905 em ações IMRX

Diretor da Immuneering, Feinberg, compra US$ 86 mil em ações

Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55%

E.U.A. - Ações fecharam o pregão inalteradas e o Índice Dow Jones Industrial Average avançou 0,55%

Alibaba, Costco among market cap stock movers on Thursday

Costco, Alibaba among market cap stock movers on Thursday

Dow Jumps Over 250 Points; US Initial Jobless Claims Increase - Acrivon Therapeutics (NASDAQ:ACRV), Cormedix (NASDAQ:CRMD)

Nasdaq Falls Over 100 Points; Acuity Posts Upbeat Earnings - Acrivon Therapeutics (NASDAQ:ACRV), Acuity (NYSE:AYI)

Why Is Immuneering Stock Trading Lower Today? - Immuneering (NASDAQ:IMRX)